FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis

Wen, 2008, Malignant gliomas in adults, N. Engl. J. Med., 359, 492, 10.1056/NEJMra0708126 Ostrom, 2015, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012, Neuro-Oncology, 17, iv1, 10.1093/neuonc/nov189 Bush, 2017, Current and future strategies for treatment of glioma, Neurosurg. Rev., 40, 1, 10.1007/s10143-016-0709-8 Toms, 2017, Recent advances in the treatment of gliomas - comprehensive brain tumor center, R. I. Med. J., 100, 43 Delgado-Lopez, 2016, Survival in glioblastoma: a review on the impact of treatment modalities, Clin. Transl. Oncol., 18, 1062, 10.1007/s12094-016-1497-x Bartonicek, 2016, Long noncoding RNAs in cancer: mechanisms of action and technological advancements, Mol. Cancer, 15, 43, 10.1186/s12943-016-0530-6 Schmitt, 2016, Long noncoding RNAs in cancer pathways, Cancer Cell, 29, 452, 10.1016/j.ccell.2016.03.010 Kiang, 2015, Long non-coding RNAs: the key players in glioma pathogenesis, Cancers (Basel), 7, 1406, 10.3390/cancers7030843 Peng, 2018, New insights into long noncoding RNAs and their roles in glioma, Mol. Cancer, 17, 61, 10.1186/s12943-018-0812-2 Hamilton, 2018, Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma, Oncotarget, 9, 23670, 10.18632/oncotarget.25330 Liu, 2020, LncRNA FGD5-AS1 can be predicted as therapeutic target in oral cancer, J. Oral Pathol. Med., 49, 243, 10.1111/jop.12989 Fan, 2020, Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1, Biosci. Rep., 40, 10.1042/BSR20193309 Li, 2019, Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e, In Vitro Cell. Dev. Biol. Anim., 55, 577, 10.1007/s11626-019-00376-x Fang, 2016, Roles, functions, and mechanisms of long non-coding RNAs in cancer, Genomics Proteomics Bioinformatics, 14, 42, 10.1016/j.gpb.2015.09.006 Zhu, 2018, Functional long noncoding RNAs (lncRNAs) in clear cell kidney carcinoma revealed by reconstruction and comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network, Med. Sci. Monit., 24, 8250, 10.12659/MSM.910773 Xu, 2014, Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression, J. Hematol. Oncol., 7, 63, 10.1186/s13045-014-0063-7 Yoon, 2014, Functional interactions among microRNAs and long noncoding RNAs, Semin. Cell Dev. Biol., 34, 9, 10.1016/j.semcdb.2014.05.015 Diao, 2018, MiR-129-5p inhibits glioma cell progression in vitro and in vivo by targeting TGIF2, J. Cell. Mol. Med., 22, 2357, 10.1111/jcmm.13529 Gu, 2018, MicroRNA-129-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting DNMT3A, Am. J. Transl. Res., 10, 2834 Barboro, 2014, Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression, Cancer Lett., 352, 152, 10.1016/j.canlet.2014.06.019 Zhang, 2012, Wnt/beta-catenin signaling in glioma, J. NeuroImmune Pharmacol., 7, 740, 10.1007/s11481-012-9359-y Zhang, 2016, Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer, Cancer Lett., 376, 62, 10.1016/j.canlet.2016.03.022 Khaled, 2015, Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide, Drug Discov. Today, 20, 899, 10.1016/j.drudis.2015.02.011 Donche, 2019, The path toward PET-guided radiation therapy for glioblastoma in laboratory animals: a mini review, Front. Med., 6, 5, 10.3389/fmed.2019.00005 Bhan, 2017, Long noncoding RNA and cancer: a new paradigm, Cancer Res., 77, 3965, 10.1158/0008-5472.CAN-16-2634 Rynkeviciene, 2018, Non-coding RNAs in glioma, Cancers, 11, 17, 10.3390/cancers11010017 Tay, 2014, The multilayered complexity of ceRNA crosstalk and competition, Nature, 505, 344, 10.1038/nature12986 Zeng, 2018, miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma, Cell Death Dis., 9, 394, 10.1038/s41419-018-0343-1 Liu, 2020, MircoRNA-129-5p suppresses the development of glioma by targeting HOXC10, Pathol. Res. Pract., 216, 152868, 10.1016/j.prp.2020.152868 Xu, 2017, Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B, Biomed. Pharmacother., 87, 405, 10.1016/j.biopha.2016.12.100 Xu, 2019, Post-translational modification control of RNA-binding protein hnRNPK function, Open Biol., 9, 10.1098/rsob.180239 Wang, 2020, The emerging roles of hnRNPK, J. Cell. Physiol., 235, 1995, 10.1002/jcp.29186 Gallardo, 2016, Aberrant hnRNP K expression: all roads lead to cancer, Cell Cycle, 15, 1552, 10.1080/15384101.2016.1164372 Gao, 2013, Heterogeneous nuclear ribonucleoprotein K (hnRNP-K) promotes tumor metastasis by induction of genes involved in extracellular matrix, cell movement, and angiogenesis, J. Biol. Chem., 288, 15046, 10.1074/jbc.M113.466136 Chen, 2017, Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer, J. Cell. Mol. Med., 21, 1266, 10.1111/jcmm.12999 Li, 2019, Downregulation of HNRNPK in human cancer cells inhibits lung metastasis, Anim. Model. Exp. Med., 2, 291, 10.1002/ame2.12090 Peng, 2019, hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing, Cancer Cell Int., 19, 335, 10.1186/s12935-019-1020-x Huang, 2017, HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway, Oncotarget, 8, 103364, 10.18632/oncotarget.21873 Gallardo, 2015, hnRNP K is a haploinsufficient tumor suppressor that regulates proliferation and differentiation programs in hematologic malignancies, Cancer Cell, 28, 486, 10.1016/j.ccell.2015.09.001 He, 2019, Wnt/β-catenin signaling cascade: a promising target for glioma therapy, J. Cell. Physiol., 234, 2217, 10.1002/jcp.27186 Li, 2018, Long noncoding RNA pancEts-1 promotes neuroblastoma progression through hnRNPK-mediated β-catenin stabilization, Cancer Res., 78, 1169, 10.1158/0008-5472.CAN-17-2295